1. Impacts of bisphosphonates on the bone and its surrounding tissues: mechanistic insights into medication-related osteonecrosis of the jaw
    Bhumrapee Srivichit et al, 2022, Archives of Toxicology CrossRef
  2. Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?
    Gül Merve Yalcin-Ülker et al, 2023, Biomedicines CrossRef
  3. Positive effect of pentoxifylline on medication-related osteonecrosis of the jaw
    J. Li et al, 2020, Journal of Stomatology, Oral and Maxillofacial Surgery CrossRef
  4. Titanium implant alters the effect of zoledronic acid on the behaviour of endothelial cells
    Yi Yu et al, 2022, Oral Diseases CrossRef
  5. IL‐17A is involved in the hyperplasia of blood vessels in local lesions of psoriasis by inhibiting autophagy
    Juanjuan Wang et al, 2024, Journal of Cosmetic Dermatology CrossRef
  6. Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials
    Henrik Holtmann et al, 2018, Journal of International Medical Research CrossRef
  7. Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
    Aya Alsalih et al, 2021, Dentistry Journal CrossRef
  8. Upregulation of DAPK2 ameliorates oxidative damage and apoptosis of placental cells in hypertensive disorder complicating pregnancy by suppressing human placental microvascular endothelial cell autophagy through the mTOR signaling pathway
    Yan Wang et al, 2019, International Journal of Biological Macromolecules CrossRef
  9. New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
    Lan-Lan Bu et al, 2023, International Journal of Molecular Sciences CrossRef